go back

Tixagevimab and Cilgavimab Injection, Home or Residence

New York rates for HCPCS M0221

Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known SARS-CoV-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available COVID-19 vaccine is not recommended due to a history of severe adverse reaction to a COVID-19 vaccine(s) and/or COVID-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency

Rates data updated July 2026.

Facilitymedian $240 · 10th–90th $204$2400%50%10th$240Professionalmedian $288 · 10th–90th $240$5010%10%20%10th90th$288$200.0$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Excellus BCBS
Setting
Professional
Modifier
Global
Typical Low
$239.88
Median
$338.84
Typical High
$588.84
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$251.19
Median
$251.19
Typical High
$251.19
United
Setting
Professional
Modifier
Global
Typical Low
$257.04
Median
$288.40
Typical High
$501.19
Univera
Setting
Facility
Modifier
Global
Typical Low
$204.17
Median
$239.88
Typical High
$239.88
Univera
Setting
Professional
Modifier
Global
Typical Low
$141.25
Median
$239.88
Typical High
$588.84